MELISSA MIAO: Open Payments
NPI 1588924922 · KEARNY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,390 in 267 payments from 26 companies in 2025. Trend: 2023 $2,967 · 2024 $3,348 · 2025 $4,390
Food & beverage: $4,286Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $602 |
| Janssen Biotech, Inc. | 26 | $554 |
| Novartis Pharmaceuticals Corporation | 16 | $352 |
| PFIZER INC. | 19 | $325 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 26 | $306 |
| Arcutis Biotherapeutics, Inc. | 21 | $285 |
| LEO Pharma Inc. | 13 | $267 |
| Incyte Corporation | 12 | $220 |
| Regeneron Healthcare Solutions, Inc. | 13 | $217 |
| Galderma Laboratories, L.P. | 16 | $215 |
Products named: TREMFYA, RINVOQ, CIBINQO, Zoryve, DUPIXENT, ADBRY, SKYRIZI, OPZELURA.
Industry payments across NJ — which companies pay providers there.
